Seqirus
Chemicals & Related Products · Canada · 201-500 Employees
View Company Info for Free
Overview
Headquarters
16766 Transcanada Hwy Ste 504, Kirkland,...Phone Number
(844) 392-8582Website
www.seqirus.caRevenue
$61.3 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
3
1
1
1
1
About Seqirus
Seqirus is part of CSL Limited (ASX:CSL), headquartered in Melbourne, Australia. The CSL Group of companies employs more than 20,000 people with operations in more than 60 countries. Seqirus was established on July 31, 2015 following CSL's acquisition of the Novartis influenza vaccines business. As one of the largest influenza vaccine providers in the world, Seqirus is a major contributor to the prevention of influenza and a transcontinental partner in pandemic preparedness. Seqirus operates state-of-the-art production facilities in the U.S., the UK and Australia, and manufactures influenza vaccines using both egg-based and cell-based technologies. It has leading R&D capabilities, a broad portfolio of differentiated products and a commercial presence in more than 20 countries.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Seqirus your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Seqirus has recently received funding, and reach out quickly before it becomes old news!
Check out if Seqirus is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Seqirus
Funding: Get notified immidiatlly once Seqirus has new funding data
Product Launch: Get notified when Seqirus launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Click to see if Seqirus had a recent Job posting/layoffs
Earning: See what the market has to say on Seqirus recently announced quarterly report
Seqirus, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Seqirus
Find more new buyers
Compare Similar Companies to Seqirus
Compare insights from companies similar to Seqirus, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Seqirus
$61.3M
201-500
Private
-
2015
N/A
Company Profile Activity
Activity Insights
Seqirus is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Seqirus is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Seqirus.
Seqirus Tech Stack
A closer look at the technologies used by Seqirus
See more technologies
Top Chemicals & Related Products Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Seqirus
Sign Up For FreeTo access detailed company insights
Seqirus is part of CSL Limited (ASX:CSL), headquartered in Melbourne, Australia. The CSL Group of companies employs more than 20,000 people with operations in more than 60 countries. Seqirus was established on July 31, 2015 following CSL's acquisition of the Novartis influenza vaccines business. As one of the largest influenza vaccine providers in... Read More
